Light therapy device study for newborns with severe brain bleeding

This study looks at ways to prevent, find early, and manage bleeding in the brain and the fluid buildup that can follow in premature babies. If your baby had such bleeding and fluid buildup, the study may offer close monitoring and care to help improve outcomes.

This study looks at premature babies who are born very early and weigh very little, to understand bleeding in the brain (called intraventricular hemorrhage). If your baby is eligible, the research may help doctors learn more about this condition and how to manage it.

This Phase 1 trial studies whether giving erythropoietin (EPO) and melatonin is safe in very preterm infants who have bleeding in the brain (intraventricular hemorrhage) or significant nearby brain injury. It aims to see if these medicines can be given safely during the early days after birth.

This study uses a special light-based monitor (NIRS) to track blood flow in the brain of premature infants. It compares babies in different conditions related to bleeding, fluid buildup, or other brain fluid changes to help doctors understand what monitoring can show.

This study looks at using two noninvasive tools on very preterm newborns to better predict whether an intraventricular hemorrhage (bleeding in the brain’s fluid spaces) may happen. If successful, it could help doctors spot risk earlier and monitor or treat babies sooner.

This trial tests a procedure called neuroendoscopic lavage, which uses a small camera and fluid to gently wash out blood from the fluid spaces in a newborn's brain after a severe bleeding. It aims to reduce pressure and help prevent further damage.